ST-segment Elevation Myocardial Infarction (STEMI) Clinical Trial
Official title:
The Effect of Morning vs Evening Aerobic Exercise Training on Cardiac Remodeling and Function Improvement in Patients After ST Elevation Myocardial Infarction
The aim of the study was to intervene in the Aerobic exercise time of patients with STEMI and to explore the optimal exercise time for STEMI patients
Cardiovascular disease (CVD) remains the first cause of mortality worldwide. More than 30% of CVD-connected fatalities are ascribed to ST-segment Elevation myocardial infarction (STEMI). There is strong and consistent evidence that aerobic exercise after a STEMI improves overall and cardiovascular-related mortality. Aerobic exercise (AE) acts in key mechanisms of cardiac remodeling and function improvement after STEMI, thus contributing both to prevent or postpone harmful adaptations, and even to recover from negative alterations caused by cardiac ischemia. However, the time of day to exercise for STEMI patients' optimal cardiac benefits is currently unknown. The circadian clock endows the host with temporal precision and robust adaptation to the surrounding environment. Almost all physiologic, metabolic and endocrine processes, including glycolysis, lipid and carbohydrate metabolism as well as cardiovascular function (heart rate, blood pressure) are influenced by the circadian clock. Recent investigations in rodents utilizing gain-of-function/loss-of-function models and in humans have identified Adverse cardiovascular events have day/night patterns is related to endogenous circadian clock control of platelet activation events. Several studies have also demonstrated the effect of AE at different times on blood pressure. Indeed, timing is critical in amplifying the beneficial impact of AE. However, these studies did not address cardiac structural remodeling or other CVD-related metabolic markers, it difficult to determine the physiological and structural effects of different time AE on cardiovascular health. Thus, In this trial our aim is to assess, in patients who have had an STEMI, AE in which time of a day can give the best benefits to cardiac remodeling and function improvement. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04962178 -
Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset
|
N/A | |
Not yet recruiting |
NCT04549766 -
Predictive Value of PRECISE DAPT Score in STEMI Patients After Primary PCI
|
||
Not yet recruiting |
NCT05511831 -
The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMI
|
Phase 4 | |
Completed |
NCT05649696 -
Prolonged Clinical Follow-up of OPTIMA-5
|
Phase 4 | |
Recruiting |
NCT05506449 -
The RECOVER IV Trial
|
N/A | |
Completed |
NCT01144819 -
Platelet Inhibition in the Acute Phase of STEMI
|
N/A | |
Recruiting |
NCT03539133 -
Systemic Organ Communication in STEMI
|
||
Completed |
NCT01642667 -
Pharmacoinvasive Therapy With Prourokinase
|
Phase 2/Phase 3 | |
Completed |
NCT04131816 -
HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program
|
N/A | |
Recruiting |
NCT03768453 -
EARLY-MYO-CMR Registry
|
||
Completed |
NCT04942977 -
Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy
|
N/A | |
Recruiting |
NCT04912518 -
Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction
|
N/A | |
Completed |
NCT04996901 -
The Chinese STEMI PPCI Registry (CSPR)
|
||
Recruiting |
NCT05892042 -
Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction
|
N/A | |
Completed |
NCT02197117 -
Effect of Remote Ischemic Conditioning in Heart Attack Patients
|
N/A | |
Completed |
NCT02733341 -
The Effect of IV Cangrelor and Oral Ticagrelor Study
|
Phase 4 | |
Not yet recruiting |
NCT04110691 -
Impact of Stent Length and Diameter on Patients Undergoing Primary PCI
|
||
Recruiting |
NCT05510661 -
Use of Export in Primary Percutaneous Coronary Intervention
|
N/A | |
Recruiting |
NCT05709626 -
PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
|
Phase 4 | |
Recruiting |
NCT05046483 -
Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI
|